Korro Bio KRRO
NASDAQ KRRO
$9.86 -0.05 (-0.50%)
As of: Oct 1, 2026 · 9:37 AM EDT

Korro Bio (KRRO) Short term Debt (2021 - 2023)

Updated

Korro Bio's Short term Debt was $11.67 million in Q1 2023, up 250.0% from $3.33 million a year earlier and up 16.7% from the prior quarter.

Analysis

Korro Bio (KRRO) Short term Debt (2021 - 2023) Analysis & Trends

At the end of FY2022, Short term Debt at Korro Bio came in at $10 million.

  • In earlier years, Short term Debt was $833,000 in FY2021.
  • Per Business Quant data, KRRO's Short term Debt in the three quarters before Q1 2023 was $10 million (Q4 2022), $8.33 million (Q3 2022) and $5.83 million (Q2 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Korro Bio 145.73 Mn -250.91 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 11.67 Mn
Dec 31, 2022 10.00 Mn
Sep 30, 2022 8.33 Mn
Jun 30, 2022 5.83 Mn
Mar 31, 2022 3.33 Mn
Dec 31, 2021 833,000.00
API Access

Korro Bio Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=KRRO&period=max&api_key=YOUR_API_KEY